180 related articles for article (PubMed ID: 27049829)
1. LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway.
Jia J; Shi Y; Yan B; Xiao D; Lai W; Pan Y; Jiang Y; Chen L; Mao C; Zhou J; Xi S; Cao Y; Liu S; Tao Y
Oncotarget; 2016 May; 7(19):27280-94. PubMed ID: 27049829
[TBL] [Abstract][Full Text] [Related]
2. A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis.
Gu D; Fan Q; Zhang X; Xie J
J Biol Chem; 2012 Nov; 287(45):38356-66. PubMed ID: 22992748
[TBL] [Abstract][Full Text] [Related]
3. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
[TBL] [Abstract][Full Text] [Related]
4. Role of IKKα in skin squamous cell carcinomas.
Park E; Liu B; Xia X; Zhu F; Jami WB; Hu Y
Future Oncol; 2011 Jan; 7(1):123-34. PubMed ID: 21174543
[TBL] [Abstract][Full Text] [Related]
5. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
Tilley C; Deep G; Agarwal C; Wempe MF; Biedermann D; Valentová K; Kren V; Agarwal R
Mol Carcinog; 2016 Jan; 55(1):3-14. PubMed ID: 25492239
[TBL] [Abstract][Full Text] [Related]
6. IKKα Induces Epithelial-Mesenchymal Changes in Mouse Skin Carcinoma Cells That Can Be Partially Reversed by Apigenin.
García-García VA; Alameda JP; Page A; Mérida-García A; Navarro M; Tejero A; Paramio JM; García-Fernández RA; Casanova ML
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163299
[TBL] [Abstract][Full Text] [Related]
7. DDX5 Silencing Suppresses the Migration of Basal cell Carcinoma Cells by Downregulating JAK2/STAT3 Pathway.
Quan Z; Zhang BB; Yin F; Du J; Zhi YT; Xu J; Song N
Technol Cancer Res Treat; 2019; 18():1533033819892258. PubMed ID: 31870221
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
Shi FT; Yu M; Zloty D; Bell RH; Wang E; Akhoundsadegh N; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
Mol Med Rep; 2017 Apr; 15(4):1441-1454. PubMed ID: 28259916
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.
Huang WC; Chen WS; Chen YJ; Wang LY; Hsu SC; Chen CC; Hung MC
J Cell Physiol; 2012 Apr; 227(4):1446-54. PubMed ID: 21618535
[TBL] [Abstract][Full Text] [Related]
12. IKK(α) controls canonical TGF(ß)-SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in panc1 cells.
Brandl M; Seidler B; Haller F; Adamski J; Schmid RM; Saur D; Schneider G
J Cell Sci; 2010 Dec; 123(Pt 24):4231-9. PubMed ID: 21081648
[TBL] [Abstract][Full Text] [Related]
13. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B
Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
15. IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin.
Liu B; Willette-Brown J; Liu S; Chen X; Fischer SM; Hu Y
Cell Death Differ; 2011 Dec; 18(12):1854-64. PubMed ID: 21566664
[TBL] [Abstract][Full Text] [Related]
16. p16 gene expression in basal cell carcinoma.
Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
18. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
19. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal stem cell markers in skin and adnexal malignancies.
Quist SR; Eckardt M; Kriesche A; Gollnick HP
Br J Dermatol; 2016 Sep; 175(3):520-30. PubMed ID: 26914519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
